The vaccine has already passed clinical tests and it was developed in the Institute of Clinical immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk .
Currently, it’s being administered to patients by injection at the third and fourth stages of cancer.
“We are deriving dendritic cells from the human body and loading them with tumour antigens.
“Dendritic cells method them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they’re actively fighting the tumour.”
The institute’s creation “is not a classical vaccine, that is the means to stop the illness”, Kozlov said. “In fact, it’s a cell therapy.”
The vaccine is counteracting many forms of cancer – colorectal (bowel) cancer, breast cancer and prostate cancer – and the institute is prepared to start its industrial production, Kozlov added.
However, the scientist added that other forms of therapy were to be used as well, such as chemotherapy and radiation therapy.